Shoppers Drug Mart Corp (SC.TO)

DON'T BUY
Stock is almost reaching its fair market value. Stock is extended.
TOP PICK
Doing a great job in the beauty and cosmetics area. Prescription drugs keeps a steady flow of traffic. Expects 13/15% earnings growth.
DON'T BUY
A good company. Seems a bit expensive. Have a good strategy. Wait for some weakness.
BUY
Likes their strategy in expanding their beauty lines. Demographically very strong. Reasonable value here.
BUY
A great franchise. Good management. A slow, steady performer. Probably 15% earnings per share growth. P/E multiple is very reasonable.
BUY
(A past pick June 4/03. Up 21%.) Getting pricey but a good retail. Paying down debt. Worth its premium.
PAST TOP PICK
(Top pick on July 3/03. Up 9.9%.) Still likes. A defensive strategy. Still a buy.
PAST TOP PICK
(Top pick Jun 24/03. Up 5%.) Still likes. Strong management. Good products. Holding for the long haul.
DON'T BUY
Some of the easier cost cutting has already been done. Growth may slow down. Trading at 20 X earnings.
DON'T BUY
Near their model price of $27/$28.
BUY ON WEAKNESS
One-year target has been $28 and its getting pretty close now.Numbers have been good.Growth will probably come from Québec.Should have 10 to 15% growth over the next couple of years.Would buy $2/3 lower.
BUY
There are a lot of sellers waiting in the wings.Still trading at a discount to what its worth.
BUY
Still has more room to grow. A great core holding for a conservative portfolio.
BUY
A superb company. Growth outlook remains strong. Likes their cosmetics growth.
TOP PICK
Strong management. Demographics are favourable. Good growth strategy.
Showing 376 to 390 of 452 entries